199 related articles for article (PubMed ID: 31384998)
1. One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.
Christou N; Mathonnet M; Gaujoux S; Cadiot G; Deguelte S; Kraimps JL; Lifante JC; Menegaux F; Mirallié E; Muscari F; Carnaille B; Pattou F; Sauvanet A; Goudet P
World J Surg; 2019 Nov; 43(11):2856-2864. PubMed ID: 31384998
[TBL] [Abstract][Full Text] [Related]
2. Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study.
Santucci N; Gaujoux S; Binquet C; Reichling C; Lifante JC; Carnaille B; Pattou F; Mirallié E; Facy O; Mathonnet M; Goudet P
World J Surg; 2021 Jun; 45(6):1794-1802. PubMed ID: 33649917
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
Goudet P; Murat A; Binquet C; Cardot-Bauters C; Costa A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Delemer B; Beckers A; Bonithon-Kopp C
World J Surg; 2010 Feb; 34(2):249-55. PubMed ID: 19949948
[TBL] [Abstract][Full Text] [Related]
4. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
5. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
Vinault S; Mariet AS; Le Bras M; Mirallié E; Cardot-Bauters C; Pattou F; Ruszniewski P; Sauvanet A; Chanson P; Baudin E; Elias D; Menegaux F; Gaujoux S; Borson-Chazot F; Lifante JC; Caron P; Carrère N; Tabarin A; Laurent C; Klein M; Brunaud L; Niccoli P; Sebag F; Cadiot G; Kianmanesh R; Luu M; Binquet C; Goudet P
Ann Surg; 2020 Dec; 272(6):1094-1101. PubMed ID: 30585820
[TBL] [Abstract][Full Text] [Related]
6. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
[TBL] [Abstract][Full Text] [Related]
7. Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.
Lecomte P; Binquet C; Le Bras M; Tabarin A; Cardot-Bauters C; Borson-Chazot F; Lombard-Bohas C; Baudin E; Delemer B; Klein M; Vergès B; Aparicio T; Cosson E; Beckers A; Caron P; Chabre O; Chanson P; Du Boullay H; Guilhem I; Niccoli P; Rohmer V; Guigay J; Vulpoi C; Scoazec JY; Goudet P
World J Surg; 2018 Jan; 42(1):143-152. PubMed ID: 28785839
[TBL] [Abstract][Full Text] [Related]
8. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
[TBL] [Abstract][Full Text] [Related]
9. Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up.
Giudici F; Cavalli T; Giusti F; Gronchi G; Batignani G; Tonelli F; Brandi ML
World J Surg; 2017 Sep; 41(9):2312-2323. PubMed ID: 28429092
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
[TBL] [Abstract][Full Text] [Related]
11. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
Goudet P; Murat A; Cardot-Bauters C; Emy P; Baudin E; du Boullay Choplin H; Chapuis Y; Kraimps JL; Sadoul JL; Tabarin A; Vergès B; Carnaille B; Niccoli-Sire P; Costa A; Calender A;
World J Surg; 2009 Jun; 33(6):1197-207. PubMed ID: 19294466
[TBL] [Abstract][Full Text] [Related]
12. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
[TBL] [Abstract][Full Text] [Related]
13. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
14. Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort.
van Beek DJ; Nell S; Vorselaars WMCM; Bonsing BA; van Eijck CHJ; van Goor H; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; ; Borel Rinkes IHM; Vriens MR
Ann Surg Oncol; 2021 Aug; 28(8):4387-4399. PubMed ID: 33521900
[TBL] [Abstract][Full Text] [Related]
15. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
Bartsch DK; Fendrich V; Langer P; Celik I; Kann PH; Rothmund M
Ann Surg; 2005 Dec; 242(6):757-64, discussion 764-6. PubMed ID: 16327485
[TBL] [Abstract][Full Text] [Related]
16. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
Goudet P; Bonithon-Kopp C; Murat A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Cadiot G; Beckers A; Guilhem I; Chabre O; Caron P; Du Boullay H; Verges B; Cardot-Bauters C
Eur J Endocrinol; 2011 Jul; 165(1):97-105. PubMed ID: 21551167
[TBL] [Abstract][Full Text] [Related]
17. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.
Triponez F; Goudet P; Dosseh D; Cougard P; Bauters C; Murat A; Cadiot G; Niccoli-Sire P; Calender A; Proye CA;
World J Surg; 2006 May; 30(5):654-62; discussion 663-4. PubMed ID: 16680582
[TBL] [Abstract][Full Text] [Related]
18. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
Albers MB; Manoharan J; Bollmann C; Chlosta MP; Holzer K; Bartsch DK
World J Surg; 2019 Feb; 43(2):552-558. PubMed ID: 30288555
[TBL] [Abstract][Full Text] [Related]
19. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
Nell S; Borel Rinkes IHM; Verkooijen HM; Bonsing BA; van Eijck CH; van Goor H; de Kleine RHJ; Kazemier G; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; Vriens MR;
Ann Surg; 2018 Feb; 267(2):352-356. PubMed ID: 27811505
[TBL] [Abstract][Full Text] [Related]
20. The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group.
van den Broek MFM; de Laat JM; van Leeuwaarde RS; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Kerstens MN; Bisschop PH; Havekes B; Hackeng WM; Brosens LAA; Vriens MR; Buikhuisen WA; Valk GD
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1014-e1027. PubMed ID: 33135721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
